Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 13Oropharyngeal Neoplasms 12Lung Neoplasms 9Laryngeal Neoplasms 8Carcinoma 8Mouth Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Mesothelioma, Malignant 6Hypopharyngeal Neoplasms 6Uterine Cervical Neoplasms 5Nasopharyngeal Carcinoma 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Ovarian Neoplasms 3Lymphoid Interstitial Pneumonia 3Gallbladder Neoplasms 3Testicular Neoplasms 2Seminoma 2Paranasal Sinus Neoplasms 2Medulloblastoma 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Wilms Tumor 1Vulvar Neoplasms 1

Interventions

enasidenib 1dehydroftorafur 1Radiotherapy 1Radiation 1Platinum 1Fluorouracil 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × Platinum × 90 days × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡